Skip to main content

Table 2 Grading and management of CRS

From: Macrophage, the potential key mediator in CAR-T related CRS

Grade

Grading assessment

Treatmenta

Modified CTCAE 4.0b

CTCAE 5.0 [41],c

Anti-IL-6 Therapy

Corticosteroids

Additional supportive care

Grade 1

Symptoms are not life threatening and require symptomatic treatment only

Fever, nausea, fatigue, headache, myalgias, malaise

Fever (≥ 38 °C)

For prolonged CRS (> 3 days) in patients with significant symptoms and/or comorbidities, consider tocilizumab as per Grade 2

N/A

Empiric broad-spectrum antibiotics, consider granulocyte colony-stimulating factor (G-CSF) if neutropenic

Maintenance IV fluids for hydration

Symptomatic management of organ toxicities

Grade 2

Symptoms require and respond to moderate intervention

Oxygen requirement < 40% or

Hypotension responsive to fluids or low dose of one vasopressor or

Grade 2 organ toxicity

Fever with hypotension not requiring vasopressors and/or

Hypoxia requiring low-flow nasal cannula or blow-by

Tocilizumab 8 mg/kg IV over 1 h (not to exceed 800 mg/dose)

Repeat in 8 h if no improvement; no more than 3 doses in 24 h, with a maximum of 4 doses total

For persistent refractory hypotension after 1–2 doses of anti-IL-6 therapy: Dexamethasone 10 mg IV every 6 h (or equivalent)

IV fluid bolus as needed

For persistent refractory hypotension after two fluid boluses and anti-IL-6 therapy: Start vasopressors, consider transfer to intensive care unit (ICU), consider echocardiogram, and initiate other methods of hemodynamic monitoring

Manage per Grade 3 if no improvement within 24 h after starting anti-IL-6 therapy

Symptomatic management of organ toxicities

Grade 3

Symptoms require and respond to aggressive intervention

Oxygen requirement ≥ 40% or

Hypotension requiring high dosed or multiple vasopressors or

Grade 3 organ toxicity or grade 4 transaminitis

Fever with hypotension requiring a vasopressor with or without vasopressin and/or

Hypoxia requiring high-flow cannula, face mask, nonrebreather mask, or Venturi mask

Anti-IL-6 therapy as per Grade 2

if maximum dose not reached within 24 h period

Dexamethasone 10 mg IV every 6 h (or equivalent). If refractory, manage as grade 4

Transfer to ICU, obtain echocardiogram, and perform hemodynamic monitoring

Supplemental oxygen.

IV fluid bolus and vasopressors as needed

Symptomatic management of organ toxicities

Grade 4

Life-threatening symptoms

Requirement for ventilator support or

Grade 4 organ toxicity (excluding transaminitis)

Fever with hypotension requiring multiple vasopressors (excluding vasopressin) and/or

Hypoxia requiring positive pressure (eg, CPAP, BiPAP, intubation and mechanical ventilation)

Anti-IL-6 therapy as per Grade 2 if maximum dose not reached within 24 h period

Dexamethasone 10 mg IV every 6 h (or equivalent). If refractory, consider methylprednisolone 1000 mg/day IV

ICU care and hemodynamic monitoring

Mechanical ventilation as needed

IV fluid bolus and vasopressors as needed

Symptomatic management of organ toxicities

  1. CTCAE Common Terminology Criteria for Adverse Events, BiPAP bilevel positive airway pressure, CPAP continuous positive airway pressure therapy, IV intravenous
  2. aCCN Clinical Practice Guidelines in Oncology, Management of Immunotherapy‑Related Toxicities (Version 1.2020)
  3. bRevised CRS grading system based on CTCAE v4.0 by Lee et al. [3]
  4. cFever is defined as temperature > 38 °C not attributable to any other cause. In patients who have CRS then receive antipyretics or anti-cytokine therapy such as tocilizumab or steroids, fever is no longer required to grade subsequent CRS severity. In this case, CRS grading is driven by hypotension and/or hypoxia
  5. dsee specific definition of high-dose vasopressors [42]